glp-1 gastroparesis class action in kentucky Gastroparesis: Hidden Dangers Beyond C semaglutide gastroparesis legal team in

Patients must have held a diagnosis of type 2 diabetes mellitus (ICD-10: E11) as well as an HbA1c of at least 6.5%

The drug will likely become pricier via self-pay as doses increase, though Novo Nordisk hasn't disclosed those prices yet

"I work out regularly

Glucagon-like peptide-1 is a hormone that the gut releases after you eat

"GLP-1 Patient Access Report Q3/Q4 2025." Last updated: December 2025 Reviewed monthly as formularies and coverage policies change Disclaimer The information on this page is for educational and informational purposes only and is not intended as medical advice

Clinical trials show meaningful weight loss for many people while they are taking the medication, but withdrawal data also shows significant regain after stopping